“Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy” (2023) Brazilian Journal of Pharmaceutical Sciences, 59, p. e21414. doi:10.1590/s2175-97902023e21414.